type here...

Tag:#Chrystal Capital Partners

Press Releases

Chrystal Capital Acts As Exclusive Advisor To Change Agronomy On £9.6m Fundraise

CHRYSTAL Capital Partners LLP, is an entrepreneurial corporate finance and investment house with an established global network of Single Family Offices (SFOs), Ultra High...
BusinessCann -
News

Is CBD A Boom-Or-Bust Fad – Or A Major FMCG Opportunity?

SUGGESTIONS that CBD is a fad - a boom-to-bust market - with the latter imminent, raised a few eyebrows at Cannabis Europa.  In an occasionally...
Peter -
Press Releases

Successful £7.5m financing for Yooma Wellness Concurrent To A Dual-Listing Onto The UK’s AQSE Growth Market

CHRYSTAL Capital Partners LLP, Europe’s leading cannabis corporate finance and investment house, is pleased to announce that it has acted as European Capital Markets...
BusinessCann -
News

Channel Island Firm Secures Britain’s First High-THC Commercial Cultivation Licence For Over 20 Years

CHANNEL islands company Northern Leaf has successfully secured a medical cannabis cultivation licence to produce medicines for the UK and European markets. The Jersey Government,...
Peter -
News

New Medical Cannabis Charity Offering Support To Patients Frozen Out By NHS

THE UK’s first charity designed to support patients seeking medical cannabis has been approved by the regulator. The London-based Sapphire Medical Foundation told BusinessCann it...
Peter -
News

Over 500 Deals Pitched To $200m UK Cannabis Fund

NEWLY-LAUNCHED legal medicinal cannabis fund Verdite Capital plans to make its first investments in the spring of 2021 - with team members having already...
Peter -
Markets

Markets: New $200m London Cannabis Fund, Nestlé, Institutional Investors, Aurora et al…

LONDON-based investors Chrystal Capital Partners have announced plans to launch ‘Europe’s biggest cannabis fund’. The corporate finance firm hopes to raise an initial $100m for...
Peter -

Latest news

News

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img
News

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...
Press Releases

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read

Editor Picks

Must Read

BusinessCann

About BusinessCann

BusinessCann delivers news, features, comment and analysis with the people and businesses forging Europe’s hemp, medicinal cannabis and CBD wellness sectors.

Advertise | Contact Us | Terms & Conditions | Privacy Policy | Disclaimer

Follow Us

© 2023 - BusinessCann.com. All Rights Reserved.